|
Amerise Biosciences Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
4.23 Cr.
|
P/BV
|
0.79
|
Book Value (Rs.)
|
0.81
|
|
52 Week High/Low (Rs.)
|
1/1
|
FV/ML
|
1/1
|
P/E(X)
|
800.00
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.00
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.00 | -0.02 | -0.02 | 0.08 | -0.05 |
| Diluted EPS (Rs.) | 0.00 | -0.02 | -0.02 | 0.08 | -0.05 |
| Cash EPS (Rs.) | 0.00 | -0.02 | -0.01 | 0.08 | -0.05 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 0.81 | 0.81 | 0.83 | 0.85 | 0.77 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 0.81 | 0.81 | 0.83 | 0.85 | 0.77 |
| Revenue From Operations / Share (Rs.) | 0.00 | 0.00 | 0.00 | 1.36 | 0.00 |
| PBDIT / Share (Rs.) | 0.00 | -0.02 | -0.01 | 0.08 | -0.05 |
| PBIT / Share (Rs.) | 0.00 | -0.02 | -0.01 | 0.08 | -0.05 |
| PBT / Share (Rs.) | 0.00 | -0.02 | -0.01 | 0.08 | -0.05 |
| Net Profit / Share (Rs.) | 0.00 | -0.02 | -0.01 | 0.08 | -0.05 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 0.00 | 0.00 | 0.00 | 6.09 | 0.00 |
| PBIT Margin (%) | 0.00 | 0.00 | 0.00 | 6.09 | 0.00 |
| PBT Margin (%) | 0.00 | 0.00 | 0.00 | 6.09 | 0.00 |
| Net Profit Margin (%) | 0.00 | 0.00 | 0.00 | 6.09 | 0.00 |
| Return on Networth / Equity (%) | 0.10 | -2.71 | -2.15 | 9.73 | -6.62 |
| Return on Capital Employeed (%) | 0.14 | -2.71 | -2.11 | 9.59 | -6.62 |
| Return On Assets (%) | 0.06 | -2.71 | -2.10 | 4.58 | -5.99 |
| Long Term Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Total Debt / Equity (X) | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 0.00 | 0.00 | 0.00 | 1.02 | 0.00 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 0.01 | 1.48 | 0.36 | 0.99 | 0.03 |
| Quick Ratio (X) | 0.01 | 1.48 | 0.36 | 0.99 | 0.03 |
| | | | | | |
| COVERAGE RATIOS | | | | | |
| | | | | | |
| Interest Coverage Ratio (%) | 39.00 | -486.00 | -1188.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (Post Tax) (%) | 29.50 | -486.00 | -1188.00 | 0.00 | 0.00 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 5.99 | 4.34 | 4.70 | 9.06 | 10.88 |
| EV / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 1.01 | 0.00 |
| EV / EBITDA (X) | 767.96 | -29.76 | -39.57 | 16.49 | -32.28 |
| MarketCap / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 |
| Price / BV (X) | 1.12 | 0.81 | 0.83 | 1.59 | 2.14 |
| Price / Net Operating Revenue (X) | 0.00 | 0.00 | 0.00 | 0.99 | 0.00 |
| EarningsYield | 0.00 | -0.03 | -0.02 | 0.06 | -0.03 |
